Insulin mimetics foil obesity

Obesity is on the increase in industrialized countries and is a serious risk factor for diabetes and cardiovascular disorders, but effective pharmaceutical treatments for obesity remain elusive. In February Nature Medicine, Ellen Air and colleagues from University of Cincinnati College of Medicine, Cincinnati, Ohio, show that small molecule insulin mimetics can reduce food intake and body weight and prevent development of obesity in an animal model.Air et al. found the central intracerebroventri

By | February 6, 2002

Obesity is on the increase in industrialized countries and is a serious risk factor for diabetes and cardiovascular disorders, but effective pharmaceutical treatments for obesity remain elusive. In February Nature Medicine, Ellen Air and colleagues from University of Cincinnati College of Medicine, Cincinnati, Ohio, show that small molecule insulin mimetics can reduce food intake and body weight and prevent development of obesity in an animal model.

Air et al. found the central intracerebroventricular administration of two insulin like nonpeptidyl compounds (Cpd1 and Cpd2) caused a dose-dependent reduction of food intake and body weight in rats. They suggested that Cpd might alter the expression of hypothalamic genes known to regulate food intake. In addition, unlike insulin itself, the oral administration of the small molecule insulin mimetics reduced body weight gain, adiposity and insulin resistance in a murine model of obesity (Nat Med 2002, 8:179-183).

These results "demonstrate the unique advantage of small molecule insulin mimetics over insulin in controlling body weight and provide proof-of-principle for a novel approach for the treatment of obesity and related metabolic disorders" concluded the authors.

Popular Now

  1. Exercise Boosts Telomere Transcription
  2. Neurons Compete to Form Memories
  3. Classic Example of Symbiosis Revised
  4. The Genetic Components of Rare Diseases
RayBiotech